Investors & Media

Stock Info

NASDAQBCLI

Recent News

May 19, 2023

BrainStorm Cell Therapeutics Summarizes Key Messages from Its Participation as Expert Speakers in an Invited Presentation and Panel Discussion at The 2023 ALS Drug Development Summit

- Presentation by Co-CEO Stacy Lindborg, Ph.D., held at 2023 ALS Drug Development Summit - Summit Focused On Transforming Translational Tools to Accelerate Future ALS Approvals NEW YORK, May 19,...

May 15, 2023

BrainStorm Cell Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update

Biologics License Application for NurOwn® for the treatment of ALS to be subject of an upcoming FDA Advisory Committee Meeting Conference call and webcast at 8:00 a.m. Eastern Time today NEW...

May 9, 2023

BrainStorm to Announce First Quarter 2023 Financial Results and Provide a Corporate Update

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today that it will hold a conference call to update...

View All

Events

First Quarter 2023 Financial Results and Corporate Update Call

Monday, May 15, 2023

8:00am EDT

Participant Numbers:
Toll Free: 877 545 0523
International: 973 528 0016
Entry Code: 771387

Replay Numbers:
Toll Free: 877 481 4010
International: 919 882 2331
Replay Passcode: 48424

Press Release

View All

Email Alerts

Email Alerts

Investor Contact